Hepatitis C drug Gilead's sofosbuvir to get FDA Approval

Check out the positive review of Gilead Sciences Inc's hepatitis C drug - Sofosbuvir given by the ‘U.S. Food and Drug Administration’ (FDA).

Gilead Sciences’ much-anticipated hepatitis C drug, named as Sofosbuvir, has been given the thumbs up by an FDA advisory group. All 15 members of the Food and Drug Administration’s panel of virus experts have voted in favor of approving Sofosbuvir, a daily